Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00882596 · ClinicalTrials.gov registry record · Phase 4
Use of the Contura™ Catheter to Deliver Accelerated Partial Breast Irradiation to "Low-risk" Breast Cancer Patients
A Phase 4 study of Breast Cancer, sponsored by Cancer Center of Irvine.
- Completed
- Registry status
- Phase 4
- Development phase
- 30
- Enrollment target
- 1
- Study location
NCT00882596: Completed Phase 4 study of Breast Cancer, sponsored by Cancer Center of Irvine.
NCT00882596 is a Phase 4 study of Breast Cancer that has completed, run by Cancer Center of Irvine. The registered enrollment target is 30 participants, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00882596, a Phase 4 study of Breast Cancer, has completed, sponsored by Cancer Center of Irvine.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this national, multi-site study is to determine the safety and effectiveness of the Contura catheter in breast cancer patients undergoing accelerated partial breast irradiation.
Conditions Studied
Interventions
- DEVICE Accelerated partial breast irradiation
Study Locations (1)
California
- Cancer Center of Irvine - Irvine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2008-05 |
| Est. Completion | 2013-07 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00882596
The ClinicalTrials.gov registry entry for NCT00882596 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (99% lower). The listed sponsor is Cancer Center of Irvine, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Breast Cancer appearing as the primary indexed condition, and to 1 intervention - of which Accelerated partial breast irradiation is the first listed.
NCT00882596 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT00882596 about?
NCT00882596 is a clinical study titled "Use of the Contura™ Catheter to Deliver Accelerated Partial Breast Irradiation to "Low-risk" Breast Cancer Patients". The purpose of this national, multi-site study is to determine the safety and effectiveness of the Contura catheter in breast cancer patients undergoing accelerated partial breast irradiation.
What is the current status of trial NCT00882596?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 30 participants. The study started on 2008-05. Estimated completion is 2013-07.
What conditions does trial NCT00882596 study?
This clinical trial studies the following conditions: Breast Cancer.
What interventions are being tested in trial NCT00882596?
The interventions under investigation include: Accelerated partial breast irradiation (DEVICE).
Who is sponsoring clinical trial NCT00882596?
This trial is sponsored by Cancer Center of Irvine, which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00882596 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Breast Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Brain [18F]-FES PET/CT in Patients With Estrogen-Receptor Positive Breast Cancer
RECRUITING · Phase 4
-
Liposomal Bupivacaine Vs Bupivacaine with Dexmedetomidine in Erector Spinae Plane Blocks for Mastectomies
RECRUITING · Phase 4
-
Role of TXA in Patients Undergoing Breast Free Flap Reconstruction
RECRUITING · Phase 4
-
Pharmacokinetic Study of Skeletal Muscle Area-based Paclitaxel Infusion in Patients With Cancer
RECRUITING · Phase 4
-
CEM to Reduce Biopsy Rates for Less Than Highly Suspicious Breast Abnormalities: a Prospective Study
RECRUITING · Phase 4
-
Abemaciclib Dose Escalation to Maintain Intensity (ADE-MI)
RECRUITING · Phase 4
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.